Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M MacDonald

Showing results (91-100 of 187) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|February 19, 2015
Poster advertisements in practice waiting rooms to recruit patients to the Treatment In Morning vs. Evening (TIME) online studyD Rorie, R Flynn, L McConnachie, et al.
Journal of Human Hypertension|November 1, 1996
Indomethacin does not attenuate the hypotensive effect of trandolaprilG Pritchard, D Lyons, J Webster, et al.
Annals of Internal Medicine|January 1, 1996
Impaired exercise tolerance in hypertensive patientsP O Lim, R J MacFadyen, P B Clarkson, et al.
European Journal of Clinical Pharmacology|January 1, 1990
A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart diseaseT M MacDonald, R F Jeffrey, A L Muir, et al.
European Heart Journal|November 1, 1995
Acute effects of atrial natriuretic peptide on left ventricular diastolic function. a pulsed wave Doppler study in manP B Clarkson, N M Wheeldon, C Macleod, et al.
Journal of Human Hypertension|May 24, 2000
High prevalence of primary aldosteronism in the Tayside hypertension clinic populationP O Lim, E Dow, G Brennan, et al.
Lancet (London, England)|February 19, 1999
Potentially high prevalence of primary aldosteronism in a primary-care populationP O Lim, P Rodgers, K Cardale, et al.
Journal of Hypertension|February 12, 1998
Safe withdrawal of monotherapy for hypertension is poorly effective and not likely to reduce health-care costsN Prasad, P G Davey, A D Watson, et al.
Heart (British Cardiac Society)|October 20, 1999
Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assaysA D Struthers, G Anderson, R J MacFadyen, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activityA D Struthers, G Anderson, R J MacFadyen, et al.
Pageof 19

Showing results (91-100 of 187) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|February 19, 2015
Poster advertisements in practice waiting rooms to recruit patients to the Treatment In Morning vs. Evening (TIME) online studyD Rorie, R Flynn, L McConnachie, et al.
Journal of Human Hypertension|November 1, 1996
Indomethacin does not attenuate the hypotensive effect of trandolaprilG Pritchard, D Lyons, J Webster, et al.
Annals of Internal Medicine|January 1, 1996
Impaired exercise tolerance in hypertensive patientsP O Lim, R J MacFadyen, P B Clarkson, et al.
European Journal of Clinical Pharmacology|January 1, 1990
A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart diseaseT M MacDonald, R F Jeffrey, A L Muir, et al.
European Heart Journal|November 1, 1995
Acute effects of atrial natriuretic peptide on left ventricular diastolic function. a pulsed wave Doppler study in manP B Clarkson, N M Wheeldon, C Macleod, et al.
Journal of Human Hypertension|May 24, 2000
High prevalence of primary aldosteronism in the Tayside hypertension clinic populationP O Lim, E Dow, G Brennan, et al.
Lancet (London, England)|February 19, 1999
Potentially high prevalence of primary aldosteronism in a primary-care populationP O Lim, P Rodgers, K Cardale, et al.
Journal of Hypertension|February 12, 1998
Safe withdrawal of monotherapy for hypertension is poorly effective and not likely to reduce health-care costsN Prasad, P G Davey, A D Watson, et al.
Heart (British Cardiac Society)|October 20, 1999
Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assaysA D Struthers, G Anderson, R J MacFadyen, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 6, 2002
Nonadherence with ACE inhibitors is common and can be detected in clinical practice by routine serum ACE activityA D Struthers, G Anderson, R J MacFadyen, et al.
Pageof 19